.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Daiichi Sankyo
Citi
US Army
Colorcon
Cerilliant
Cipla
Moodys
Express Scripts
Medtronic

Generated: July 25, 2017

DrugPatentWatch Database Preview

CLEOCIN Drug Profile

« Back to Dashboard

What is the patent landscape for Cleocin, and when can generic versions of Cleocin launch?

Cleocin is a drug marketed by Pharmacia And Upjohn and is included in fourteen NDAs. There is one patent protecting this drug.

This drug has twenty-one patent family members in twenty-two countries.

The generic ingredient in CLEOCIN is clindamycin phosphate. There are fifty-two drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the clindamycin phosphate profile page.

Summary for Tradename: CLEOCIN

Patents:1
Applicants:1
NDAs:14
Suppliers / Packagers: see list3
Bulk Api Vendors: see list102
Clinical Trials: see list7
Patent Applications: see list1,052
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CLEOCIN at DailyMed

Pharmacology for Tradename: CLEOCIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn
CLEOCIN
clindamycin hydrochloride
CAPSULE;ORAL061809-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
CLEOCIN T
clindamycin phosphate
LOTION;TOPICAL050600-001May 31, 1989ABRXYesYes► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
CLEOCIN
clindamycin phosphate
CREAM;VAGINAL050680-001Aug 11, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
CLEOCIN
clindamycin phosphate
SWAB;TOPICAL050537-002Feb 22, 1994ATRXYesNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
CLEOCIN PHOSPHATE
clindamycin phosphate
INJECTABLE;INJECTION062803-001Oct 16, 1987APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: CLEOCIN

Country Document Number Estimated Expiration
Canada2378572► Subscribe
Peru04842001► Subscribe
Slovenia1200065► Subscribe
TaiwanI232111► Subscribe
World Intellectual Property Organization (WIPO)0110407► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: CLEOCIN

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
401Luxembourg► SubscribePRODUCT NAME: CLINDAMYCINE(EN TANT QUE PHOPSHATE DE CLINDAMYCINE)ET TRETINOINE
1304992/01Switzerland► SubscribePRODUCT NAME: CLINDAMYCINI PHOSPHAS ET TRETINOINUM; REGISTRATION NO/DATE: SWISSMEDIC 62513 28.03.2014
00617Netherlands► SubscribePRODUCT NAME: COMBINATIE VAN CLINDAMYCINE, DESGEWENST IN DE VORM VAN CLINDAMYCINEFOSFAAT EN TRETINOINE; NAT. REGISTRATION NO/DATE: RVG 109745 20130626; FIRST REGISTRATION: PA1332/043/001 20130322
13/044Ireland► SubscribePRODUCT NAME: CLINDAMYCIN AND TRETINOIN; REGISTRATION NO/DATE: PA1332/043/001 20130322
2013 00053Denmark► SubscribePRODUCT NAME: CLINDAMYCIN (SOM CLINDAMYCIN PHOSPHATE) OG TRETINOIN; NAT. REG. NO/DATE: 48954 20130416; FIRST REG. NO/DATE: IE PA1332/043/001 20130322
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
UBS
Johnson and Johnson
Daiichi Sankyo
Covington
Teva
Queensland Health
Fuji
Cipla
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot